2026 NPPES data Otolaryngology Physician NPI 1972512382 M.D.
Verify on CMS →

RABINDRA BRAGANZA, M.D.

Otolaryngology Physician in SANTA BARBARA, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 400 beneficiaries · Otolaryngology Physician avg: 509
Generic prescribing
99%
generic claims · 1% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$31.14
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

RABINDRA BRAGANZA, M.D. filed 1,187 Medicare Part D claims in 2023 as a Otolaryngology Physician in SANTA BARBARA, California, prescribing 99% generic.

1K
Part D claims, 2023
99%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RABINDRA BRAGANZA, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,187 Top 23% higher than 77% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). This entry sits in this band. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

RABINDRA BRAGANZA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RABINDRA BRAGANZA, M.D.?

Quality data not reported

NPI registry status

Active

Issued 08/05/2006

NPI 1972512382

Primary specialty

Otolaryngology Physician

Mid-sized

10,895 US NPIs in this specialty

Medicare Part D claims

1,187 133% vs specialty avg

2023 prescription claims

Specialty avg: 509

Specialty distribution in California

How Otolaryngology Physician compares to other specialties among California providers

California providers

Otolaryngology Physician share within California

1. Otolaryngology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Otolaryngology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Otolaryngology Physician ABMS/AOA estimate

Est. board-certified rate (Otolaryngology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Otolaryngology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RABINDRA BRAGANZA, M.D. appears in the CMS NPPES registry as a Otolaryngology Physician provider holding M.D. credentials at 4151 FOOTHILL RD, SANTA BARBARA, CA, 93110, with a listed phone of (805) 681-7500. NPI 1972512382 was issued on 08/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BRAGANZA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,187 prescription claims written by this provider, covering 400 Medicare beneficiaries and totaling roughly $24K in drug spend, split 1% brand-name and 99% generic by claim count, with an opioid prescribing rate of 2.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Otolaryngology Physician is a mid-sized specialty nationwide, with 10,895 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4151 FOOTHILL RD
SANTA BARBARA, CA 93110

Provider Details

NPI 1972512382
Specialty Otolaryngology Physician
Credentials M.D.
Gender Male
NPI Issued 08/05/2006

Hospital and facility affiliations

Facilities where RABINDRA BRAGANZA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SANSUM CLINIC
SANTA BARBARA, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RABINDRA BRAGANZA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$31

Largest payer

Hikma Pharmaceuticals USA

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to RABINDRA BRAGANZA, M.D.. To verify RABINDRA BRAGANZA, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

RABINDRA BRAGANZA, M.D. — brand share 1.0%
Specialty average (est.)

1% brand-name claims vs 99% generic, on 1,187 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,187
Total Claims
$24K
Total Drug Cost
400
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,345
Total Day Supply
65,839
Brand vs Generic
1% brand / 99% generic
Brand Drug Cost
$325
Generic Drug Cost
$23K
Opioid Claims
27 (2.3% rate)
Antibiotic Claims
90

Patient Demographics

Average Patient Age
75.1 years
Avg HCC Risk Score
1.05
Gender Split
58% female / 42% male
Age Distribution
<65: 11, 65-74: 193, 75-84: 152, 85+: 44

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RABINDRA BRAGANZA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Famotidine
410
Fluticasone Propionate
206
Omeprazole
137
Azelastine Hcl
85
Ipratropium Bromide
43
Montelukast Sodium
42
Ciprofloxacin Hcl
29
Pantoprazole Sodium
22
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
21
Triamterene-Hydrochlorothiazid
Triamterene/Hydrochlorothiazid
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngology Physician Overview

How RABINDRA BRAGANZA, M.D. fits within the Otolaryngology Physician landscape nationally.

10,895
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
509
Avg Claims per Provider

RABINDRA BRAGANZA, M.D.'s 1,187 claims are above the specialty average of 509.

Nearby Otolaryngology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BRAGANZA.

Compare Otolaryngology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RABINDRA BRAGANZA, M.D.'s specialty?
RABINDRA BRAGANZA, M.D. specializes in Otolaryngology Physician and practices in SANTA BARBARA, California. Credentials: M.D..
How much does RABINDRA BRAGANZA, M.D. prescribe under Medicare Part D?
In 2023, RABINDRA BRAGANZA, M.D. wrote 1,187 Medicare Part D claims totaling $24K in drug costs for 400 beneficiaries.
Where is RABINDRA BRAGANZA, M.D. located?
RABINDRA BRAGANZA, M.D. is located at 4151 FOOTHILL RD, SANTA BARBARA, CA, 93110. Phone: (805) 681-7500.
What is RABINDRA BRAGANZA, M.D.'s NPI number?
RABINDRA BRAGANZA, M.D.'s National Provider Identifier (NPI) is 1972512382, issued on 08/05/2006.
Does RABINDRA BRAGANZA, M.D. prescribe more brand-name or generic drugs?
RABINDRA BRAGANZA, M.D.'s prescribing is 1% brand-name and 99% generic drugs by claim count, with $325 in brand drug costs.
Does RABINDRA BRAGANZA, M.D. prescribe opioids?
Yes, RABINDRA BRAGANZA, M.D. had 27 opioid claims in 2023 with an opioid prescribing rate of 2.3%.
How many Otolaryngology Physician providers are there in the US?
There are 10,895 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 509 Medicare Part D claims per year.
What drugs does RABINDRA BRAGANZA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, RABINDRA BRAGANZA, M.D.'s most frequently prescribed drugs include Famotidine, Fluticasone Propionate, Omeprazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RABINDRA BRAGANZA, M.D. accept Medicare?
RABINDRA BRAGANZA, M.D. appears in CMS Medicare data with 1,187 Part D claims and 400 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RABINDRA BRAGANZA, M.D.'s credentials?
RABINDRA BRAGANZA, M.D.'s NPI is 1972512382 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology